Karyopharm Therapeutics Inc. buy melinda
Start price
13.01.18
/
50%
€9.89
Target price
25.01.18
€10.10
Performance (%)
2.55%
End price
25.01.18
€10.15
Summary
This prediction ended on 25.01.18 with a price of €10.15. With a performance of 2.55%, the BUY prediction by melinda for Karyopharm Therapeutics Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | -4.857% | -4.857% | -44.008% | -89.080% |
| iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
| iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
| iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
| iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by melinda for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
Starten der Testphase 3 am 7. Juni angekündigt, wird 2017. Anmeldung im Jahr 2018 mit den Daten im Jahr 2019 aufgrund abgeschlossen sein.
Stopped prediction by melinda for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.42
25.08.20
25.08.20
€15.00
04.11.21
04.11.21
-43.59%
05.11.21
05.11.21
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.60
01.03.20
01.03.20
€17.00
25.08.20
25.08.20
-14.93%
25.08.20
25.08.20
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.04
28.03.19
28.03.19
€8.12
03.07.19
03.07.19
62.79%
03.07.19
03.07.19
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.72
06.03.18
06.03.18
€17.05
17.05.18
17.05.18
16.42%
17.05.18
17.05.18
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.96
28.01.18
28.01.18
€12.45
08.02.18
08.02.18
13.66%
08.02.18
08.02.18
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.36
07.03.17
07.03.17
€12.45
30.03.17
30.03.17
9.31%
30.03.17
30.03.17